Options for phage therapy in gynecological practice
Infectious inflammatory pelvic diseases, in spite of a widespread clinical use of antimicrobials, remain a challenge for obstetrics, gynecology and perinatology. They are a cause of infertility, recurrent miscarriage, placental insufficiency and intrauterine fetal infection. Equally important is also a reduced quality of life due to chronic pelvic pain. Phage therapy for the purpose of treatment and prevention is a very promising area in addressing the problem.